GlassScriptPhysician profile
Walter D Costa
NPI 1548336605
$36,817.36
in general payments reported to CMS, 2019-2025
38 companies · $13K in 2025
The $13K reported for 2025 was more than what 97% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,002 · 2020: $836 · 2021: $1,000 · 2022: $5,623 · 2023: $1,454 · 2024: $8,700 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $5,211 · Travel and Lodging: $3,621 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $12,025.00 |
| Food and Beverage | $5,210.87 |
| Travel and Lodging | $3,621.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $14,957.31 | 2023-2025 | |
| Smith+Nephew, INC. | $10,026.99 | 2019-2025 | Collagenase Santyl, Grafix Pl, Grafix |
| Polymedics Innovations INC. | $3,797.50 | 2023-2024 | |
| Musculoskeletal Transplant Foundation INC. | $1,565.24 | 2019-2021 | |
| Stryker Corporation | $1,199.52 | 2019-2023 | Spy-Phi System, Augment Injectable, Citrefix |
| Polarityte, INC. | $1,012.72 | 2019 | |
| Kci USA, INC. | $867.78 | 2019 | |
| Organogenesis INC. | $403.87 | 2022-2024 | Puraply, Puraply Franchise |
| Osiris Therapeutics INC. | $392.39 | 2019 | |
| Abbott Laboratories | $378.49 | 2019-2025 | Eterna, Proclaim |
| Aroa Biosurgery Incorporated | $365.70 | 2022 | |
| Biotissue Holdings INC. | $238.70 | 2024-2025 | |
| Paratek Pharmaceuticals, INC. | $154.02 | 2024-2025 | Nuzyra |
| Zimmer Biomet Holdings, INC. | $151.99 | 2019-2020 | |
| Medline Industries LP | $146.13 | 2019 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $109.46 | 2020-2021 | |
| Melinta Therapeutics, LLC | $107.82 | 2019 | |
| Nevro Corp. | $102.56 | 2022-2024 | Senza |
| Access Pro Medical, LLC | $92.82 | 2022 | |
| Solventum Corporation | $77.93 | 2024-2025 | Activ.A.C., V.A.C.Ulta, Promogran Prisma |
| Treace Medical Concepts, INC. | $75.46 | 2022-2025 | |
| Acell, INC. | $66.71 | 2019-2020 | |
| Bioventus LLC | $65.82 | 2019-2025 | Exogen Ultrasound Bone Healing System |
| Celularity INC. | $65.00 | 2019 | |
| Kerecis Limited | $60.86 | 2021 | |
| Orthofix Medical, INC. | $54.10 | 2022-2025 | Physio-Stim |
| Evolution Surgical, INC | $43.66 | 2020-2024 | |
| Sanara Medtech INC. | $37.95 | 2021 | |
| Medtronic Vascular, INC. | $28.89 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $27.94 | 2025 | |
| Paragon 28, INC. | $23.48 | 2023 | Portfolio |
| Pfizer INC. | $21.93 | 2021 | |
| Resmed Corp | $17.49 | 2022 | |
| Checkpoint Surgical, INC | $17.13 | 2021 | |
| Reprise Biomedical, INC. | $16.16 | 2025 | Miro3d |
| Urgo Medical North America, LLC | $16.10 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Tactile Systems Technology INC | $15.74 | 2019 | |
| Wright Medical Technology, INC. | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Walter D Costa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.